Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice. (Q52203591)
Jump to navigation
Jump to search
scientific article published in January 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice. |
scientific article published in January 1996 |
Statements
Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice. (English)
1 reference
Hengemihle JM
1 reference
Abugo O
1 reference
Rifkind J
1 reference
Spangler E
1 reference
Danon D
1 reference
Ingram DK
1 reference
1 January 1996
1 reference
59
1 reference
1
1 reference
153-156
1 reference